NCT02374112Active, not recruiting
Creatine Supplementation in Chronic Fatigue Syndrome
The Effects of Medium-term Creatine Supplementation in Adults With Chronic Fatigue Syndrome
Source: ClinicalTrials.gov · Last updated 23 May 2025
Brief summary (registry, in English)
This study evaluates the effectiveness of medium-term supplementation with creatine to improve clinical outcomes in well-defined adult CFS population. Half of the participants will receive creatine while the other half will receive placebo.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 60 (actual)
- First submitted
- 22 Feb 2015
- Start date
- Jan 2016
- Primary completion date
- Dec 2025
- Lead sponsor
- Center for Health Sciences, Serbia
- Diseases
- Long COVID and ME/CFS
- NCT number
- NCT02374112
What you commit to
- Study type: Interventional
- Participants enrolled: 60
- From Jan 2016 to the primary completion date, Dec 2025
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- use of dietary supplement within 4-weeks prior to the study commencing
Other illness
- psychiatric co-morbidity
Other
- pregnancy
Who the study is looking for
- older than 18 years
- fulfilled CDC criteria for CFS
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.